Nicole Eter (University of Muenster, Germany) talks about the growing prevalence of retinopathy of prematurity and the latest findings of the RAINBOW study, along with an update on OCT-A and how it has changed clinical practice over recent years.
Questions:
1. What are the limitations of the current standard of care for retinopathy of prematurity? (0:04)
2. Could you tell us a little about the RAINBOW study and its findings to date? (1:04)
3. How have the advances in OCT-A changed clinical practice over the past few years? (1:45)
4. Can you tell us about the current research and developments in OCT-A? (2:33)
Support: No funding was received in the production of this video.
